Breast cancer trends: a marriage between clinical trial evidence and epidemiology.

[1]  J. Peterse,et al.  Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations , 2008, Breast Cancer Research and Treatment.

[2]  R. Rawal,et al.  Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy , 2008, Breast Cancer Research and Treatment.

[3]  Robert N Hoover,et al.  Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. , 2007, Journal of the National Cancer Institute.

[4]  Jasmin A. Tiro,et al.  Reported drop in mammography , 2007, Cancer.

[5]  Michael J Thun,et al.  Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women , 2007, Breast Cancer Research.

[6]  Eric J Feuer,et al.  The decrease in breast-cancer incidence in 2003 in the United States. , 2007, The New England journal of medicine.

[7]  K. Malone,et al.  Interactions between Body Mass Index and Hormone Therapy and Postmenopausal Breast Cancer Risk (United States) , 2006, Cancer Causes & Control.

[8]  Ingvar Andersson,et al.  Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study , 2006, BMJ : British Medical Journal.

[9]  H. Jonsson,et al.  Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden , 2005 .

[10]  D. Miglioretti,et al.  Hormone Therapy Prescribing Patterns in the United States , 2004, Obstetrics and gynecology.

[11]  John Robbins,et al.  National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.

[12]  R. Stafford,et al.  National use of postmenopausal hormone therapy: annual trends and response to recent evidence. , 2004, JAMA.

[13]  R. Langer,et al.  Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial , 2003 .

[14]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[15]  A. Hartz,et al.  A comparison of observational studies and randomized, controlled trials , 2000, American journal of ophthalmology.

[16]  J. Concato,et al.  Randomized, controlled trials, observational studies, and the hierarchy of research designs. , 2000, The New England journal of medicine.

[17]  N. Black.  Why we need observational studies to evaluate the effectiveness of health care , 1996, BMJ.

[18]  V. Pinn,et al.  The evolution of the Women's Health Initiative: perspectives from the NIH. , 1995, Journal of the American Medical Women's Association.

[19]  M. Swift.  Breast cancer incidence. , 1993, Science.

[20]  T. Meade,et al.  Hormone replacement therapy and cardiovascular disease: the case for a randomized controlled trial. , 1995, Ciba Foundation symposium.